Case File
efta-02522065DOJ Data Set 11OtherEFTA02522065
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02522065
Pages
7
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Barrett, Paul S <
Sent:
Tuesday, September 11, 2012 2:28 PM
To:
Epstein, Jeffrey ([email protected])
Cc:
Giuffrida, David J; Schaffer, Susannah
Subject:
NEW HY RMBS on 10am BWIC - $8.13mm of MHL 05-2 1M1 (BBB+•) @ $70-00
(6.50% yield / 6.25 dum)
Jeffrey
=br> US Onshore Clients — Blue Sky (U.S. State Securities La=): Please confirm Blue Sky eligibility before soliciting to a US
Onshore c=ient by entering the CUSIP into the web tool located at:
http://=scppvl.amer.jpmchase.net:8080/BlueSkyPage.html and r=view to see if your client's state of residence is listed.
If you =eceive 'NO SECURITY FOUND', 'NO STATES FOUND' or t=e security DOES NOT HAVE A CUSIP or is not USD-
denominated, then ple=se contact your SM or local compliance officer and provide the requested s=curity and client
information. Please note that a suitability review and=other pre-trade procedures must still be followed.<=>
The MHL 05-2 1M1 is a Seasoned Men Floater backed by Prime H=brid ARMs. This bond is on BWIC at 10am and there
is no guarantee =e can trade this bond at our talked level.
Please call th= desk with all bids/inquiries related to this bond. X32124
HIGHLIGHTS
=DAHPI Updat=d LTV = 92%
<=span>76% of the borrowers=have not missed a payment in the past 2 years
-
= 90 months seasoned
&nb=p; 734=FICO
"Source: Bloomberg
MHL 2005.2 1M1 Offered @ 70-00
=OD
=OD
=/td>
=OA
BOND DESCRIPTION
Prepay Rate
0.5 CPR
3 CPR
Cusip:
1
EFTA_R1_01659904
EFTA02522065
61915RAD
=OD
Default Rate
=0D 5 for 30 4.5 CDR
=0A 5 ramp 24 4.5 CDR
=OD 5 ramp 18 4.5 CDR
=00
Original Face:aspan>
=span style="font-size:9.0pt;font-family:"Arial","sans-s=rif";color:S1F497D">8,130,000
width="48" nowrap="" valign="bottom" style="width:35.8pt;paddi=g:0in 5.4pt 0in 5.4pt;height:13.35pt"> Default
Severity
=OA 65 ramp 12 60 60 for 36 55</=>
55 ramp 12 45
</=d>
Current Face:
=OD 2,080,970
=span style="font-size:9.0ptfont-family:Arial","sans-s=rif";color:black">Advance (% of P&I)
<=td> 85
85<=o:p>
=OD Bond Type:
0e=inq Rate
11 Percent
Ratings (S&P/Moodys/F=tch):
BBB+/*/N RI-
=/td>
Balance Forgiveness=o:p>
0.02 for 20 0 =0A
0.01 for 20 0=0D
C=rrent Coupon:
2
EFTA_R1_01659905
EFTA02522066
0.676%
=0A
=00
Yield @ Base Case
</=d> Price=@ 70-00
Stress Case=/p>
Base Case
Recovery Case
<=d width="206" nowrap="" valign="bottom" style="width:154.6pt;bac=ground:gD7E4BC;padding:Oin 5.4pt Oin
5.4ptheight:13.35pt">
W=L @ Base Case
8.=2
5.310
=OD 6.5=5
7=2E924
Principal Window @ Base Case
<=td> Sp=ead over Tsy
381</=>
671
=OD
10.45%
=OD
=OD Duration
6.53</=pan>
6.25
=OA Current Credi= Enhancement:
11.24%
=OA
WAL
=OD
<=pan style="font-size:9.0ptfont-family:"Arial","sans-serif";color:black">9.12
8.82
7.74=/o:p>
3
EFTA_R1_01659906
EFTA02522067
60+ De=inquencies
10.17 <=span>
=OD
Principal Window
=OA
Sep12 to Jan3S
Sepl2=to Apr35
60+ Delinquency C=verage
1.11x
=OD
=OD Principal Writedown
=OD 19.89%
10.45%
0.00%
=OA
Total Collat Loss<=p>
=p class="MsoNormal" align="center" style="text-align:center">10.20%
9.47%
7.91%
=OA
UNDERLYING COLLATERAL DESCRIPTION
<=td> <=d width="169" nowrap="" valign="bottom" style="width:126.7pt;pad=ing:0in 5.4pt 0in 5.4ptheight:14.15pt">
Total Liquidation
=OD 40.65%<=p>
=OA
36.74%
=OA
Average Loan Balance ($,000s)
=OA 276
=OD
Loan Count
=/td> 580
HISTORICAL PERFORMANCE
4
EFTA_R1_01659907
EFTA02522068
=OD =OD
</=pan>
Mortgage Type
<=td> Prime Hybrid ARMs
1 MOS
3 MOS
=OD Wtd Avg Mortgage=Coupon
3.012%
=OD
=OD CPR
cd width="150" nowrap="" valign="bottom" style="width:112.2pt;pad=ing:0in 5.4pt 0in 5.4ptheight:13.35pt">
0=2E28
1.73
=0A 2.18
Wtd Avg FICO Score
734
=OD
CDRap> =0A
6.62
3.38
Wtd Avg Orig boan-to-Value
=OD
<=pan style="font-size:9.Opt;font-family:"Arial","sans-se=if";color:#1F4970">69.62%
SEV
50.96
5
EFTA_R1_01659908
EFTA02522069
=OD
<=pan style="font-size:9.0ptfont-family:"Arial",nsans-se=incolor:#1F497D">60.70
48.=9
HP= Adj LT/
=/td>
=OA
=OA
Weighted Avg Loan Age
90</=:p>
=OA
=OD
<=r style="height:13.35pt"> 82.8=
=OD
=/tr>
CA 56%
=OA
Top 2 Geo Concentration</=:p>
AZ 7%
=OD
=OD Top 3 Geo Con=entration
FL 6%
=OA
=OD
Always Current (24 mos)
76.=1%
=OA
=OD
IMPORTANT DISCLAIMER:
Non-agen=y RMBS is a complex fixed income product and is not suitable for all inves=ors. Please note that while desk
assumptions are driven by a numbe= of collateral and macro factors, the historical performance of a=deal is not
indicative of its future performance. Additionally= this message is a product of sales and trading and is not a research
repo=t. Other key risks to consider are outlined below:
All investments ar= subject to possible loss of principal
- &n=sp;
Non-Agency bonds may have limited liqu=dity and clients should be aware that the secondary market for
mortgage-ba=ked securities has experienced periods of illiquidity and may do so =n the future. Illiquidity means that
there may not be any purchasers for=your class of certificates. Although any class of certificates may exper=ence
6
EFTA_R1_01659909
EFTA02522070
illiquidity, it is more likely that classes that are lower in the cap=tal structure and non-investment grade related may
experience greate= illiquidity than more senior, investment-grade rated classes.
=OAHigh Yield N=n-Agency bonds are speculative non-investment grade bonds that have higher=risk of default or
other adverse credit events which are appropriate =for high risk investors only
Non-A=ency bonds are intended for clients with a minimum total net worth of $50m=. Please make sure your client
fulfills this requirement before so=iciting this order.=/span>
K=vin Lynn
Vice President I WMorgan Securities</=>
Desk:
=OD
=OA
This email is confid=ntial and subject to important disclaimers and conditions including on off=rs for the purchase or sale
of securities, accuracy and completeness of in=ormation, viruses, confidentiality, legal privilege, and legal entity
disc=aimers, available at http://www.jpmorgan.com/pages/disclosures/email=2E
7
EFTA_R1_01659910
EFTA02522071
Technical Artifacts (11)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Flight #
AZ7Phone
2522065Phone
2522066Phone
2522067Phone
2522068Phone
2522069Phone
2522070Phone
2522071URL
http://=scppvl.amer.jpmchase.net:8080/BlueSkyPage.htmlURL
http://www.jpmorgan.com/pages/disclosures/email=2ERelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.